Home > Healthcare > Healthcare IT > Healthcare Outsourcing > Healthcare Supply Chain Management Market
Healthcare Supply Chain Management Market size was over USD 3 billion in 2022 and will record over 12% CAGR from 2023 to 2032, owing to growing efforts for limiting drug counterfeiting.
When compared to original counterparts, adulterated, misbranded, or counterfeit pharmaceuticals have inferior attributes in terms of safety, efficacy, and quality, posing a high risk to public health. As per the CDC, in low and middle-income economies, almost 9-41% of medicines sold are counterfeit. To curb this issue, healthcare providers drug suppliers are investing heavily in healthcare supply chain management systems to bring transparency and limit the growing threat of counterfeit drugs.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Healthcare Supply Chain Management Market Size in 2022: | USD 3 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 12% |
2032 Value Projection: | USD 10.5 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 160 |
Tables, Charts & Figures: | 276 |
Segments covered: | Offering, Deployment Type, End-use, and Region. |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The steep cost of implementing healthcare supply chain management mechanisms may presents challenges to industry growth. Key aspects involved in implementation of healthcare supply chain management (SCM) systems such as software, hardware, and training, can incur high costs. Additionally, the maintenance and upgradation of these systems add to the cost of ownership of the product, which may further limit demand for healthcare SCM solutions.